enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Acute exacerbation of chronic obstructive pulmonary disease

   en.wikipedia.org/wiki/Acute_exacerbation_of...

   An acute exacerbation of chronic obstructive pulmonary disease, or acute exacerbations of chronic bronchitis (AECB), is a sudden worsening of chronic obstructive pulmonary disease (COPD) symptoms including shortness of breath, quantity and color of phlegm that typically lasts for several days.

3. Erdosteine - Wikipedia

   en.wikipedia.org/wiki/Erdosteine

   The RESTORE study (Reducing Exacerbations and Symptoms by Treatment with ORal Erdosteine in COPD) was a multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of erdosteine 300 mg/bid added to usual maintenance therapy vs. placebo over 12-months, a period long enough to avoid bias due to seasonal ...

4. Chronic obstructive pulmonary disease - Wikipedia

   en.wikipedia.org/wiki/Chronic_obstructive...

   Chronic obstructive pulmonary disease (COPD) is a type of progressive lung disease characterized by chronic respiratory symptoms and airflow limitation. [8] GOLD 2024 defined COPD as a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea or shortness of breath, cough, sputum production and/or exacerbations) due to abnormalities of the airways (bronchitis ...

5. How To Be Active in Your Treatment Journey With COPD - AOL

   www.aol.com/active-treatment-journey-copd...

   Common side effects of TRELEGY 100/62.5/25 mcg for COPD include: upper respiratory tract infection; pneumonia; bronchitis; thrush in your mouth or throat (rinse your mouth with water without ...

6. Ipratropium bromide - Wikipedia

   en.wikipedia.org/wiki/Ipratropium_bromide

   Ipratropium as an inhalant can be used for the treatment of chronic obstructive pulmonary disease (COPD) and asthma exacerbation. [16] It is supplied in a canister for use in an inhaler or in single dose vials for use in a nebulizer. [17]

7. FDA approves new COPD drug developed by firm in Raleigh ... - AOL

   www.aol.com/news/fda-approves-copd-drug...

   Second, it is anti-inflammatory, reducing COPD exacerbations or flare-ups, a sudden worsening of symptoms. Typically, anti-inflammatory action comes from inhaled corticosteroids, which can ...